Scopus
YÖKSİS DOI Eşleşti
SJR Q3
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
Viral Immunology · Nisan 2022
YÖKSİS Kayıtları
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
Viral Immunology · 2022 SCI-Expanded
Prof. Dr. HASİBE ARTAÇ →
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
Viral Immunology · 2022 SCI-Expanded
Prof. Dr. HATİCE TÜRK DAĞI →
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
Viral Immunology · 2022 SCI-Expanded
Doç. Dr. DİLEK ERGÜN →
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
Viral Immunology · 2022 SCI-Expanded
Doç. Dr. AHMET ÇİZMECİOĞLU →
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
Viral Immunology · 2022 SCI-Expanded
Prof. Dr. ŞUA SÜMER →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
2022 ISSN: 0882-8245 SCI-Expanded Q4
Doç. Dr. AHMET ÇİZMECİOĞLU →
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
2022 ISSN: 0882-8245 SCI-Expanded Q4
Prof. Dr. HASİBE ARTAÇ →
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
2022 ISSN: 0882-8245 SCI-Expanded Q4
Prof. Dr. HATİCE TÜRK DAĞI →
Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases
2022 ISSN: 0882-8245 SCI-Expanded
Doç. Dr. DİLEK ERGÜN →
Makale Bilgileri
Dergi
Viral Immunology
ISSN08828245
Yayın TarihiNisan 2022
Cilt / Sayfa35 · 273-282
Scopus ID2-s2.0-85129648604
Scimago Dergi (ISSN Eşleşmesi)
Viral Immunology
Q3
SJR Skoru0,438
H-Index73
YayıncıMary Ann Liebert Inc.
ÜlkeUnited States
Virology (Q3)
Immunology (Q4)
Molecular Medicine (Q4)
Metrikler
4
Atıf